Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GEMS (G E Medical Systems) & Amersham look to future with PET (positron emission tomography) diagnostics deal

This article was originally published in Clinica

Executive Summary

GE Medical Systems and the UK's Amersham Healthcare (formerly Nycomed Amersham Imaging) are to research ways of bringing new PET-based molecular diagnostic imaging technologies to the market. The first project under a joint agreement signed by the two companies last week will centre on the development of a PET imaging agent synthesis system to produce a new generation of targeted molecular radiopharmaceuticals.

Topics

UsernamePublicRestriction

Register

MT074207

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel